Computerized Cognitive Tests for Neurological Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests new computerized tools designed to assess brain function. Researchers aim to determine if these digital tests match or surpass traditional paper-and-pencil tests. The study involves two groups: one with neurological issues identified through brain scans and one without. Participants should not have severe dementia and must be able to complete the tests. This trial may suit individuals with or without neurological findings who can perform basic computer tasks. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance future brain assessments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these computerized cognitive tests are safe for participants?
Research has shown that computerized brain tests are generally safe for use. Studies have found that these tests provide consistent results over time, indicating they do not harm or stress participants. These tests are widely used to identify issues like mild memory loss and dementia, demonstrating their safety and utility. No major negative effects have been reported in these studies, supporting the conclusion that participants handle these tests well.12345
Why are researchers excited about this trial?
Researchers are excited about the computerized cognitive tests for neurological diseases because they offer a new, tech-driven approach to diagnosing and understanding these conditions. Unlike standard treatments that focus on medication or physical therapy, this tool uses digital neuropsychological assessments to provide more detailed insights into cognitive function. By utilizing a computerized format, it allows for more precise and consistent monitoring over time, potentially leading to earlier detection and more personalized treatment plans. This innovative approach could revolutionize how cognitive impairments are assessed and managed, offering a non-invasive and easily accessible option for patients.
What evidence suggests that this computerized tool is effective for testing cognitive functioning?
Research shows that computerized tools hold promise for assessing brain function. Studies have found these digital tools to be as reliable and accurate as traditional paper-and-pencil tests. For instance, new computerized tests effectively evaluate conditions like mild cognitive impairment (MCI) and dementia. Some studies have found that incorporating artificial intelligence (AI) in these tools enhances the accuracy of diagnosing cognitive problems. Overall, these digital tests demonstrate potential in providing accurate and efficient brain function assessments. Participants in this trial will undergo evaluation using a Computer-based Neuropsychological Tool to assess its effectiveness across different groups, including those with cerebral neurological illness (CNI) and those without.36789
Who Is on the Research Team?
Alexander Chervinsky, PhD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for men and women aged 21-65, both healthy individuals and those with significant brain findings on neuroimaging. Participants must have good perception and motor skills to do the tests but can't join if they have severe dementia or lack the necessary perceptual/motor abilities.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Testing
Participants complete both computerized and paper-and-pencil neuropsychological tests to assess reliability and validity
Follow-up
Participants are monitored for any changes in cognitive performance post-testing
What Are the Treatments Tested in This Trial?
Interventions
- Computer-based Neuropsychological Tool
Trial Overview
The study is testing three new computer-based cognitive function tests against traditional paper-and-pencil methods. It aims to see if these digital tasks are more effective by comparing results from healthy controls and patients with neurological impairments.
How Is the Trial Designed?
2
Treatment groups
Active Control
Identified from the department of Rehabilitation, Psychiatry, and Medicine and referred to the research staff via in-person communication, email or staff message
Identified from the department of Rehabilitation, Psychiatry, and Medicine and referred to the research staff via in-person communication, email or staff message
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
Citations
Moving toward the digitalization of neuropsychological tests
This study evaluates the usability of digital neuropsychological assessment tools and examines healthcare professionals' perceptions of their reliability and ...
Applications of Artificial Intelligence in the Neuropsychological ...
One study proposed a computer-aided diagnosis (CAD) system using AI to analyze CDT and provide an automatic diagnosis of cognitive impairment ( ...
Current Advances in Computerized Cognitive Assessment ...
The review highlights the advancements in computerized cognitive assessments for assessing MCI and dementia.
Predictive value of an unsupervised web-based ...
The current study examined whether functional deficits in the mnestic and attentive domain can be predicted based on an unsupervised self-administered online ...
Ensemble of models with feature space heterogeneity and ...
This study aimed to develop and validate computerized neuropsychological assessment devices for screening patients with mild cognitive impairment (MCI).
Computerized Neuropsychological Assessment Devices
This paper is intended to provide guidance for test developers and users of CNADs that will promote accurate and appropriate use of computerized tests.
Current State of Self-Administered Brief Computerized ...
We conducted a systematic review of self-administered computerized cognitive assessment measures designed for the detection of cognitive impairment in older ...
A scoping review of remote and unsupervised digital ...
Remote and unsupervised digital assessments can improve scalability, measurement reliability, and ecological validity, enabling the capture of subtle changes.
9.
alz-journals.onlinelibrary.wiley.com
alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/dad2.12083cCOG: A web‐based cognitive test tool for detecting ...
We examined accuracy and consistency of cCOG, a computerized cognitive tool, in detecting mild cognitive impairment (MCI) and dementia. Methods.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.